Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Is US FDA Biosimilars Office Next In Line For Promotion?
Nov 14 2025
•
By
Derrick Gingery
OTBB eventually could be promoted out of OND.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Biosimilars
More from United States